Revolutionizing RNA Therapeutics Research
The field of RNA therapeutics holds immense promise in targeting diseases that were previously considered 'undruggable.' With the ability to achieve results that were inaccessible to small molecules and antibodies, companies focusing on RNA therapeutics are paving the way for groundbreaking treatments. These advancements are made possible through intensive research in RNA biology and chemical modifications of oligonucleotides, mRNA, and RNA sequences to enhance their biophysical properties.
Challenges in RNA Therapeutics R&D
Traditional software designed for small molecules or antibodies lacks the necessary capabilities to support the complex requirements of RNA therapeutics research. To address this gap, a new approach is needed to integrate biological and chemical properties seamlessly. R&D teams in this field require digital solutions that can establish a unified data foundation and ensure traceability across sequences, chemical modifications, experiments, and process development.
Benchling's RNA Therapeutics Solution
Developed in collaboration with industry leaders, Benchling's RNA Therapeutics Solution offers a comprehensive platform for designing and developing natural and chemically modified oligonucleotides, mRNA, and other RNA sequences. This advanced solution enables R&D teams to centralize experimental results, standardize sequence design, and collaborate effectively, all within a single platform. By combining in silico design tools, Electronic Lab Notebook (ELN), and Laboratory Information Management System (LIMS) features, Benchling provides a modern, unified, and highly configurable solution that evolves with the dynamic needs of RNA therapeutics R&D.
Benefits of Benchling's Solution
Benchling's RNA Therapeutics Solution simplifies collaboration across multidisciplinary teams by providing intuitive design tools, centralizing experimental data, and standardizing sequence design. Moreover, it enhances data quality and offers real-time scientific insights by ensuring consistent records across experiments and aggregating results for visualization. With customizable decision support tools, Benchling accelerates the entire RNA therapeutic lifecycle by facilitating rapid iteration on oligo candidates.
Support and Expertise
Benchling's Customer Experience professionals offer dedicated expertise to support RNA therapeutic customers, combining scientific knowledge with IT best practices. Through continuous oversight and pre-implementation solutions consulting, Benchling ensures that customers derive maximum value from the platform. Additionally, R&D teams can access foundational implementation guides developed by Benchling's Customer Experience team to streamline their workflows.